Adrien Krug

Nice, 06204, France

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 12 publications

Scavenging Reactive Oxygen Species by Cerium Oxide Nanoparticles Prevents Death in a Peripheral T Cell Lymphoma Preclinical Mouse Model.

Scavenging Reactive Oxygen Species by Cerium Oxide Nanoparticles Prevents Death in a Peripheral T Cell Lymphoma Preclinical Mouse Model.

Journal: ACS nano

Published: May 09, 2025

In vivo CAR T cell therapy against angioimmunoblastic T cell lymphoma.

In vivo CAR T cell therapy against angioimmunoblastic T cell lymphoma.

Journal: Journal of experimental & clinical cancer research : CR

Published: June 06, 2024

Dependence on mitochondrial respiration of malignant T cells reveals a new therapeutic target for angioimmunoblastic T-cell lymphoma.

Dependence on mitochondrial respiration of malignant T cells reveals a new therapeutic target for angioimmunoblastic T-cell lymphoma.

Journal: Cell death discovery

Published: March 24, 2024

Inhibition of choline metabolism in an angioimmunoblastic T-cell lymphoma preclinical model reveals a new metabolic vulnerability as possible target for treatment.

Inhibition of choline metabolism in an angioimmunoblastic T-cell lymphoma preclinical model reveals a new metabolic vulnerability as possible target for treatment.

Journal: Journal of experimental & clinical cancer research : CR

Published: October 05, 2023

Repurposing the Bis-Biguanide Alexidine in Combination with Tyrosine Kinase Inhibitors to Eliminate Leukemic Stem/Progenitor Cells in Chronic Myeloid Leukemia.

Repurposing the Bis-Biguanide Alexidine in Combination with Tyrosine Kinase Inhibitors to Eliminate Leukemic Stem/Progenitor Cells in Chronic Myeloid Leukemia.

Journal: Cancers

Published: December 22, 2022

Nanoblades allow high-level genome editing in murine and human organoids.

Nanoblades allow high-level genome editing in murine and human organoids.

Journal: Molecular therapy. Nucleic acids

Published: December 08, 2022

IRE1α overexpression in malignant cells limits tumor progression by inducing an anti-cancer immune response.

IRE1α overexpression in malignant cells limits tumor progression by inducing an anti-cancer immune response.

Journal: Oncoimmunology

Published: September 01, 2022

Novel T Follicular Helper-like T-Cell Lymphoma Therapies: From Preclinical Evaluation to Clinical Reality.

Novel T Follicular Helper-like T-Cell Lymphoma Therapies: From Preclinical Evaluation to Clinical Reality.

Journal: Cancers

Published: April 14, 2022

Targeting CISH enhances natural cytotoxicity receptor signaling and reduces NK cell exhaustion to improve solid tumor immunity.

Targeting CISH enhances natural cytotoxicity receptor signaling and reduces NK cell exhaustion to improve solid tumor immunity.

Journal: Journal for immunotherapy of cancer

Published: April 06, 2022

Importance of T, NK, CAR T and CAR NK Cell Metabolic Fitness for Effective Anti-Cancer Therapy: A Continuous Learning Process Allowing the Optimization of T, NK and CAR-Based Anti-Cancer Therapies.

Importance of T, NK, CAR T and CAR NK Cell Metabolic Fitness for Effective Anti-Cancer Therapy: A Continuous Learning Process Allowing the Optimization of T, NK and CAR-Based Anti-Cancer Therapies.

Journal: Cancers

Published: November 16, 2021

Baboon Envelope Pseudotyped "Nanoblades" Carrying Cas9/gRNA Complexes Allow Efficient Genome Editing in Human T, B, and CD34+ Cells and Knock-in of AAV6-Encoded Donor DNA in CD34+ Cells.

Baboon Envelope Pseudotyped "Nanoblades" Carrying Cas9/gRNA Complexes Allow Efficient Genome Editing in Human T, B, and CD34+ Cells and Knock-in of AAV6-Encoded Donor DNA in CD34+ Cells.

Journal: Frontiers in genome editing

Published: September 09, 2020

New preclinical models for angioimmunoblastic T-cell lymphoma: filling the GAP.

New preclinical models for angioimmunoblastic T-cell lymphoma: filling the GAP.

Journal: Oncogenesis

Published: May 05, 2020

Showing 1-12 of 12

Last Updated: 09/26/2026